companydata.dkSymbiotiq ApS: Financial statements 2024
CVR: 42741809
Symbiotiq ApS (CVR 42741809) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 1,060,359 and a net result of DKK 585,824 compared with DKK 898,015 the year before. That is a decrease of 27.3% compared with the year before. Equity amounted to DKK 1,924,510. The solvency ratio was 72%.
- Gross Profit
- 1,060,359 kr.
- Profit/Loss
- 585,824 kr.
- Equity
- 1,924,510 kr.
- Total Assets
- 2,671,852 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 1.1 mio. | 586 t. | 1.9 mio. | - |
| 2023 | - | 1.5 mio. | 898 t. | 1.5 mio. | - |
How creditworthy is Symbiotiq ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2024
Symbiotiq ApS has published its annual report for 2023. Gross profit came to DKK 1,458,107, and the net result was DKK 898,015.
About Symbiotiq ApS
Symbiotiq ApS is a Danish company of the type Anpartsselskab based in Odense M, founded in 2021. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Mads Bonde. The company is owned by Mads Bonde. In 2025, the company reported a gross profit of DKK 1,352,873 and a net result of DKK 288,354 compared with DKK 585,824 the year before. Equity amounted to DKK 2,077,864.